IDH1 mutation mediated D2HG accumulation contributes to the progression of cancer cachexia and muscle atrophy. IDH1 inhibitor ivosidenib delayed the progression of cancer cachexia in murine GL261 glioma model and CT26 colorectal carcinoma models.
- Xinting Zhu
- Juan Hao
- Quanjun Yang